logo

For the Inventor, By the Inventor

Carlos Cordon-Cardo

New York, NY, United States of America

Carlos Cordon-Cardo

LinkedIn

This inventor holds 15 USPTO granted patents and 8 published patent applications and 2 EPO patents. Top assignees: Sloan-Kettering Institute for Cancer Research, Sloan-Kettering Institute, Fundação D. Anna De Sommer Champalimaud E Dr. Carlos Montez Champalimaud. Active years: 1986-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carlos Cordon-Cardo. Retrieved from https://idiyas.com/inventor/carlos-cordon-cardo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 80.0

 

Average Co-Inventor Count = 4.4

ph-index = 7

Forward Citations = 156(Granted Patents)


Company Filing History:

goldMedal9 out of 519 
 
Sloan-Kettering Institute for Cancer Research
 patents
silverMedal2 out of 11 
 
Sloan-Kettering Institute
 patents
bronzeMedal1 out of 3 
 
Fundação D. Anna De Sommer Champalimaud E Dr. Carlos Montez Champalimaud
 patents
4. 1 out of 6 
 
Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud
 patents
5. 1 out of 1,134 
 
Princeton University
 patents
6. 1 out of 834,513 
Other
 patents

Years Active: 1986-2018

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 9858389 - Method and system for determining the risk of occurrence of prostate cancer (2018-01-02),
2. 9779213 - System for evaluating a pathological stage of prostate cancer (2017-10-03),
3. 6972170 - Markers for prostate cancer (2005-12-06),
4. 6900009 - Method for creating a frozen tissue array (2005-05-31),
5. 6808887 - Uses of Ku70 (2004-10-26),
6. 6780636 - Cryoarray system and uses thereof (2004-08-24),
7. 6399298 - Ku70—related methods (2002-06-04),
8. 5843684 - Method for detecting pre-cancerous or cancerous cells using P90 (1998-12-01),
9. 5168043 - Blood group antigen panel (1992-12-01),
10. 4935344 - Method for characterizing types of renal carcinoma and prognosis (1990-06-19),
11. 4865998 - Monoclonal antibodies to human lung cancers and method (1989-09-12),
12. 4851332 - Choriocarcinoma monoclonal antibodies and antibody panels (1989-07-25),
13. 4666845 - Monoclonal antibodies to ovarian, cervical and uterine human cancers and (1987-05-19),
14. 4643971 - Monoclonal antibodies to human bladder and ureter cancers and method (1987-02-17),
15. 4579827 - Monoclonal antibodies to human gastrointestinal cancers and hybridoma (1986-04-01),

Title: Inventor Carlos Cordon-Cardo - Pioneering Innovations in New York

Introduction: Carlos Cordon-Cardo is a renowned inventor based in New York, NY, known for his groundbreaking contributions to the field of biotechnology and medical research.

Latest Patents: Carlos Cordon-Cardo holds several patents related to cancer diagnostics and treatment, including a novel method for early detection of prostate cancer and a targeted therapy for breast cancer.

Career Highlights: With a distinguished career spanning over three decades, Carlos Cordon-Cardo has held key research positions at prestigious institutions such as Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College. He has been instrumental in developing innovative technologies that have revolutionized the field of oncology.

Collaborations: Throughout his career, Carlos Cordon-Cardo has collaborated with leading scientists, clinicians, and biotech companies to translate his research findings into clinical applications. His collaborative efforts have led to the development of cutting-edge therapies for various types of cancer.

Conclusion: Carlos Cordon-Cardo's relentless pursuit of scientific excellence and his passion for improving patient outcomes have established him as a trailblazer in the field of cancer research. His innovative work continues to inspire the next generation of inventors and researchers in the quest for better treatments and cures.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…